You are here: Industry Insights > tumor

News List

Surgery May Add Years for Patients With Deadly Brain Cancer drugs
January 16, 2020
Surgical removal of the entire tumor may extend the lives of patients with a rare and deadly type of?brain cancer?called brainstem high-grade gliomas, a new study suggests.
FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors worldpharmanews
January 14, 2020
The U.S. Food and Drug Administration approved Ayvakit (avapritinib) for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) gastrointestinal stromal tumor (GIST
Aspirin appears to curb colorectal cancer recurrence and tumor growth worldpharmanews
January 09, 2020
The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and ...
Agenus Commences Phase 1 Trial with AGEN1223 americanpharmaceuticalreview
January 09, 2020
Agenus announced the dosing of the first patient with AGEN1223. AGEN1223 is a novel bi-specific antibody discovered by Agenus and designed to deplete regulatory T cells in the tumor microenvironment.
AI Beat Humans in Spotting Breast Tumors drugs
January 06, 2020
Machines can be trained to outperform humans when it comes to catching breast tumors on mammograms, a new study suggests.Researchers at Google and several universities are working on an artificial intelligence (AI) model aimed at ...
Routine HPV Testing May Be Warranted for Sinonasal Cancers drugs
January 06, 2020
Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online December?in?Cancer.
New Workflow Could Improve Imaging Assessment in Research drugs
January 03, 2020
Institutional imaging cores may help provide unbiased and reproducible measurements and enable a leaner workflow in assessing tumor measurements for patients participating in clinical trials ...
Researchers determine how a specific protein regulates tumor growth worldpharmanews
January 03, 2020
Immune checkpoints are surface proteins that cancer cells use to evade immune response. These surface proteins are critical for cancer cell growth and drugs targeting these proteins have ...
Researchers identify immune-suppressing target in glioblastoma worldpharmanews
December 24, 2019
Researchers at The University of Texas MD Anderson Cancer Center have identified a tenacious subset of immune macrophages that thwart treatment of glioblastoma with ...
Retrogenix and Resonant Therapeutics announce strategic alliance to identify targets of anti-tumour antibodies pharmaceutical-business-review
December 16, 2019
UK-based biotechnology company Retrogenix and US-based Resonant Therapeutics, Inc. announced that they have entered into a non-exclusive strategic partnership to ...